22.33
price up icon0.71%   0.3684
 
loading

Forte Biosciences Inc Azioni (FBRX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- 1.314 - -
Operating Expenses
28.19%
11.58
16.12 7.351 8.629 12.82
Operating Income/Loss
28.19%
-11.58
-16.12 -7.351 -8.629 -12.82
Income/Loss From Continuing Operations Before Tax
28.15%
-11.25
-15.66 -7.155 -8.392 -12.51
Income/Loss From Continuing Operations After Tax
28.15%
-11.25
-15.66 -7.155 -8.392 -12.51
Net Income/Loss
28.15%
-11.25
-15.66 -7.155 -8.392 -12.51
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Earnings Per Share
29.93%
-0.96
-1.37 3.18 -4.54 -0.27
Diluted Earnings Per Share
29.93%
-0.96
-1.37 3.18 -4.54 -0.27
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$38.53
price up icon 0.42%
$98.38
price down icon 0.32%
$31.57
price up icon 0.83%
$93.57
price down icon 0.31%
biotechnology ONC
$300.09
price down icon 5.87%
$196.92
price down icon 1.22%
Capitalizzazione:     |  Volume (24 ore):